This study surveyed self-medication practices among 100 pharmacy students in Satara, India. The results found that 92% of students who reported illness in the last 6 months practiced self-medication using over-the-counter drugs like NSAIDs, anti-allergics, and antacids. The top reasons for self-medication were for non-serious illnesses (49.47%) and prior experience (28.42%). Information sources for self-medication included reading materials (45.26%) and advice from others (33.68%). The study provides insight into common self-medication behaviors and information sources among pharmacy students in India.
Self-medication is a growing global concern that can contribute to antimicrobial resistance. While it provides benefits like convenience and cost savings, it also poses risks if not done properly, such as incorrect diagnosis, inappropriate treatment, and adverse drug reactions. Health professionals and pharmacists can help prevent these risks through education, guidance on proper use, and encouraging medical consultation when needed.
This document discusses self-medication and provides guidance on how to do it safely. It defines self-medication as using medicines without consulting a doctor to treat perceived or real health issues. While self-medication can help relieve costs, it may reduce monitoring and transfer financial burden to patients. The document advises consulting a pharmacist before self-medicating and provides examples of when self-medication may not be appropriate. It emphasizes the importance of responsible self-medication by being informed about proper use, dosage, and side effects of medicines.
Self-medication involves treating minor ailments without medical consultation and is common due to factors like limited access to healthcare and marketing of drugs. While it provides benefits like reduced costs and wait times, risks include incorrect diagnosis, adverse side effects from drug interactions, and development of antimicrobial resistance. Pharmacists can help mitigate these risks through education on proper medication use, counseling patients, and encouraging consultation with doctors when appropriate. Responsible self-medication requires regulation and awareness of both its benefits and potential harms.
Self-Medication is dangerous. Self-Medication may lead to Misdiagnosis of an illness, Drug interactions, Insufficient dosage, Habituation, Allergic reactions, etc. Patients should should not Self-Medicate and consult a doctor to avoid these hazards. Asking doctor a medical query has never been so easy! Lybrate has a pool of doctors available online to offer you credible medical advice. To avail an easy access to doctors across the country, anytime, anywhere download Lybrate apps and get going.
A thorough research was conducted among the individuals to understand the perspective of individuals towards self-medication. Self medication was even started for chronic diseases. The result was very surprising and new which we got to know.
1. The document discusses the concept of rational use of medicines, which refers to using the appropriate medication, in the proper dose, for an adequate amount of time, and at the lowest cost to the patient.
2. Irrational drug use can occur due to issues like lack of information, over-prescription, and promotional activities by pharmaceutical companies. It can lead to harmful effects like increased resistance and adverse drug reactions.
3. Ensuring rational drug use involves defining diagnoses accurately, selecting appropriate treatments, educating patients, and monitoring treatment responses. National essential drug lists also aim to promote the rational use of effective, affordable medicines.
Rational use of medicines means patients receive the appropriate medication for their condition in the proper dose and duration at the lowest cost. It involves evaluating the patient, specifying the treatment goal, selecting the right drug therapy, providing instructions, and regularly evaluating therapy while considering drug costs. Doctors should ask questions to ensure the right indication, drug, patient, dose, and information are considered for safe and effective treatment. Certain drug combinations should be avoided, such as anticholinergics with antipyretics, which can increase body temperature dangerously.
This document discusses self-medication and how it can lead to addiction. It notes that self-medication involves taking medications without a prescription and defines it as medicating oneself without a doctor's guidance. Certain drugs used for self-medication, like opioids, can cause dependence with long-term use and abuse. The document then presents a case study of a man who started using cocaine to treat his migraine headaches but became addicted, eventually spending $1000 every two weeks on the drug. His treatment involved therapy and prescribing alternative medications to manage his headaches.
Self-medication is a growing global concern that can contribute to antimicrobial resistance. While it provides benefits like convenience and cost savings, it also poses risks if not done properly, such as incorrect diagnosis, inappropriate treatment, and adverse drug reactions. Health professionals and pharmacists can help prevent these risks through education, guidance on proper use, and encouraging medical consultation when needed.
This document discusses self-medication and provides guidance on how to do it safely. It defines self-medication as using medicines without consulting a doctor to treat perceived or real health issues. While self-medication can help relieve costs, it may reduce monitoring and transfer financial burden to patients. The document advises consulting a pharmacist before self-medicating and provides examples of when self-medication may not be appropriate. It emphasizes the importance of responsible self-medication by being informed about proper use, dosage, and side effects of medicines.
Self-medication involves treating minor ailments without medical consultation and is common due to factors like limited access to healthcare and marketing of drugs. While it provides benefits like reduced costs and wait times, risks include incorrect diagnosis, adverse side effects from drug interactions, and development of antimicrobial resistance. Pharmacists can help mitigate these risks through education on proper medication use, counseling patients, and encouraging consultation with doctors when appropriate. Responsible self-medication requires regulation and awareness of both its benefits and potential harms.
Self-Medication is dangerous. Self-Medication may lead to Misdiagnosis of an illness, Drug interactions, Insufficient dosage, Habituation, Allergic reactions, etc. Patients should should not Self-Medicate and consult a doctor to avoid these hazards. Asking doctor a medical query has never been so easy! Lybrate has a pool of doctors available online to offer you credible medical advice. To avail an easy access to doctors across the country, anytime, anywhere download Lybrate apps and get going.
A thorough research was conducted among the individuals to understand the perspective of individuals towards self-medication. Self medication was even started for chronic diseases. The result was very surprising and new which we got to know.
1. The document discusses the concept of rational use of medicines, which refers to using the appropriate medication, in the proper dose, for an adequate amount of time, and at the lowest cost to the patient.
2. Irrational drug use can occur due to issues like lack of information, over-prescription, and promotional activities by pharmaceutical companies. It can lead to harmful effects like increased resistance and adverse drug reactions.
3. Ensuring rational drug use involves defining diagnoses accurately, selecting appropriate treatments, educating patients, and monitoring treatment responses. National essential drug lists also aim to promote the rational use of effective, affordable medicines.
Rational use of medicines means patients receive the appropriate medication for their condition in the proper dose and duration at the lowest cost. It involves evaluating the patient, specifying the treatment goal, selecting the right drug therapy, providing instructions, and regularly evaluating therapy while considering drug costs. Doctors should ask questions to ensure the right indication, drug, patient, dose, and information are considered for safe and effective treatment. Certain drug combinations should be avoided, such as anticholinergics with antipyretics, which can increase body temperature dangerously.
This document discusses self-medication and how it can lead to addiction. It notes that self-medication involves taking medications without a prescription and defines it as medicating oneself without a doctor's guidance. Certain drugs used for self-medication, like opioids, can cause dependence with long-term use and abuse. The document then presents a case study of a man who started using cocaine to treat his migraine headaches but became addicted, eventually spending $1000 every two weeks on the drug. His treatment involved therapy and prescribing alternative medications to manage his headaches.
Paracetamol is a widely used over-the-counter analgesic and antipyretic drug. It is available in many generic and branded formulations for headaches, muscle and joint pains, and reducing fever. While its exact mechanism of action is not fully understood, it is believed to work by inhibiting prostaglandin synthesis in the central nervous system. Paracetamol is generally well tolerated but can cause liver toxicity in high doses or when taken with other hepatotoxic drugs due to a toxic metabolite. It has many drug-drug interactions and its use requires monitoring in patients with liver or kidney impairment.
EBM Is the ability to access, asses and apply the best evidence from systematic research information to daily clinical problems after integrating them with the physician's experience and patient's value.
Rational prescribing,dispensing and use of drugsAhmad Ali
The document discusses rational drug use and dispensing. It defines rational drug use as using the right drug for the right patient in the right dose at the right time through the right route while ensuring cost-effectiveness. Rational dispensing involves accurately interpreting prescriptions, checking for errors, precisely filling medications, properly labeling containers with instructions, and educating patients. The key steps in rational dispensing are receiving prescriptions, interpreting instructions, checking drugs, filling accurately, labeling clearly, and providing instructions to patients.
This document discusses the rational use of antibiotics. It notes that 50% of antibiotics are used inappropriately and that many infections like diarrhea and bronchitis are viral, not bacterial. It provides details on selecting antibiotics based on the infection severity, likely bacteria, patient factors, and cost. Empiric antibiotic choices are outlined for various infections. The side effects and costs of common antibiotics are also reviewed. The document emphasizes using antibiotics appropriately only for bacterial infections.
Patient compliance describes how closely a patient follows medical advice, particularly with respect to medication, but also other treatments like device use or therapy. It is important for conditions requiring ongoing treatment, replacement therapies like insulin, or controlling diseases of public health concern. Rates of compliance are assessed through various objective and subjective methods like pill counts, health outcomes, and patient interviews. Improving compliance requires addressing barriers like cost and complex regimens through subsidization, generic drugs, and education by pharmacists and other providers.
The document defines essential medicines as those that satisfy the priority health care needs of the population at all times. It discusses how a limited essential medicines list leads to better health care, drug management, and lower costs. Essential medicines should be available at all times in adequate amounts and strengths, appropriate dosage forms, and assured quality at an affordable price. They are selected based on disease prevalence, evidence on efficacy and safety, and cost-effectiveness. The purpose of an essential medicines list is to make life-saving treatments universally accessible.
The document discusses the concept of essential medicines and rational use of drugs. It defines essential medicines as those that meet the priority health care needs of the population. The WHO publishes a Model List of Essential Medicines every two years to guide countries in developing their own national lists. Educational, managerial, economic and regulatory strategies can be used to promote rational drug use and selection of cost-effective treatments. Pharmacists can play a role through drug selection, inventory control, patient education, and pharmaceutical care.
This document provides an overview of essential drugs and the National List of Essential Medicines (NLEM) in India. It discusses the history and definition of essential drugs as developed by the WHO. Key points covered include the selection criteria and purpose of essential drug lists, as well as the development and features of India's national list. The inclusion and deletion criteria for the NLEM are presented. The importance and impact of essential drug lists at the national and state level in India is also summarized.
This document discusses promoting rational drug use in India under the National Rural Health Mission. It begins by outlining the objectives and defining the problem of irrational drug use in India. Some key points made include that India accounts for 22% of the global disease burden but only produces 2% of global drugs. It then discusses the reasons for irrational drug use, including factors related to patients, prescribers, drug regulation, and the drug supply system. Strategies presented to promote rational drug use include ensuring availability of essential drugs, access and affordability, and rational prescriptions. The challenges of implementation are also acknowledged.
This document provides an overview of drug utilization studies. It defines drug utilization studies as assessing the marketing, distribution, prescription, and use of drugs in a society with emphasis on resulting medical, social and economic consequences. The goals of such studies are to describe drug use patterns, identify early signals of irrational drug use, enable interventions to improve drug use, and provide quality control of drug use. Data sources include large databases, drug regulatory agencies, supplier data, and practice setting data. Future areas of focus include relating drug utilization data to public health trends, pharmacovigilance, pharmacoeconomics, environmental impacts, and pharmacogenetics.
For proper use of medication rational drug use (RDU) is raised. Requirements of rational drug use and it's different steps and roles of pharmacists are described here.
Essential drug concept and rational use of medicinesPravin Prasad
This document discusses the essential medicine concept and rational use of medicines. It defines essential medicines as those that meet the health needs of a population based on effectiveness, safety, and cost. Essential medicine lists include generic drug names, dosage forms, strengths, and indications. Irrational medicine use can lead to ineffective or unsafe treatment, increased costs and resistance. Rational use means using medicines appropriately for each patient's needs in terms of drug choice, dosage, duration, and cost. The document outlines various educational, managerial, regulatory and economic strategies to promote rational medicine use.
Rational use of antibiotics by Dr. Basil TumainiBasil Tumaini
Dr. Basil Tumaini presented a document on rational use of antibiotics. He discussed that antibiotics are commonly misused and overprescribed. Some key points included defining appropriate vs inappropriate antibiotic use, describing different antibiotic classes, and providing guidelines on rational prescribing like only using antibiotics for bacterial infections and avoiding unnecessary combinations. The document concluded with recommendations to only use antibiotics judiciously according to clinical guidelines and provide proper patient education.
1) Rational use of antibiotics is important to avoid adverse effects, antibiotic resistance and increased healthcare costs. Antibiotics should only be used for bacterial infections and are not needed for most viral infections.
2) In selecting an antibiotic, the aetiological agent, patient factors, pharmacokinetic properties of the drug, and efficacy of therapy should be considered. Antibiotics must achieve effective concentrations at the site of infection.
3) Guidelines provide recommendations for common infections, but clinical judgement is also needed. Empiric therapy should be modified based on culture results and the patient's response.
Pharmacovigilance involves monitoring approved drugs to detect adverse effects, assess risks, prevent harm and promote safe use. It aims to improve public health by identifying unknown risks from case reports and studies. Several methods are used including spontaneous reporting, active surveillance and observational studies. Organizations like WHO and regulatory authorities play important roles in pharmacovigilance. The goal is continual assessment of benefit-risk profiles to optimize treatment outcomes.
If you are marketing your product in India you should comply these area of regulation.We give Services in getting manufacturing licences
ACCREDITED CONSULTANTS PVT.LTD
info@acplgroupindia.co.in
+919310040434
The document discusses the concept of essential medicines. It begins by defining essential medicines as those that satisfy the priority health care needs of the majority of the population and should be available at all times in adequate amounts and affordable price. It then outlines the history of the WHO Model List of Essential Medicines, criteria for selecting essential medicines, guidelines for establishing national essential medicines programs, and advantages and disadvantages of essential medicines lists. It also summarizes recommendations from the 18th WHO Model List and 4th Essential Medicines List for Children from 2013.
This document discusses a patient-centric approach to pharmacovigilance. It emphasizes that the patient's healthcare team, which includes physicians, pharmacists, nurses, and the patient, should work together to maximize the benefits and minimize the risks of medication use. The patient should provide their medical history and discuss all medications, supplements, and therapies with their healthcare providers. It is important for patients to read and understand the patient information leaflet that comes with their medications and ask questions about anything unclear. A patient-centric approach requires patients to properly take their medications as directed and report any issues to their healthcare team.
An analysis of wrong practices among pharmacies and pharmacists in India-• Disadvantages of Self Medications Adverse Drug Reactions.Lack of knowledge about dose.Chances of using wrong medication.Risk of disease aggravation Drug interactions.
This document discusses antidepressant use in the Netherlands. It finds that while 900,000 patients are treated for depression each year, only 14% of patients meet eligibility criteria for clinical trials of antidepressants. Many patients do not continue antidepressant treatment as recommended by guidelines. Approximately 30% of patients stop treatment abruptly, experiencing discontinuation side effects, while others create homemade tapering schedules or use schedules from their doctor. The document examines patterns of initiation, adherence, and discontinuation of antidepressant treatment using pharmacy records data.
Paracetamol is a widely used over-the-counter analgesic and antipyretic drug. It is available in many generic and branded formulations for headaches, muscle and joint pains, and reducing fever. While its exact mechanism of action is not fully understood, it is believed to work by inhibiting prostaglandin synthesis in the central nervous system. Paracetamol is generally well tolerated but can cause liver toxicity in high doses or when taken with other hepatotoxic drugs due to a toxic metabolite. It has many drug-drug interactions and its use requires monitoring in patients with liver or kidney impairment.
EBM Is the ability to access, asses and apply the best evidence from systematic research information to daily clinical problems after integrating them with the physician's experience and patient's value.
Rational prescribing,dispensing and use of drugsAhmad Ali
The document discusses rational drug use and dispensing. It defines rational drug use as using the right drug for the right patient in the right dose at the right time through the right route while ensuring cost-effectiveness. Rational dispensing involves accurately interpreting prescriptions, checking for errors, precisely filling medications, properly labeling containers with instructions, and educating patients. The key steps in rational dispensing are receiving prescriptions, interpreting instructions, checking drugs, filling accurately, labeling clearly, and providing instructions to patients.
This document discusses the rational use of antibiotics. It notes that 50% of antibiotics are used inappropriately and that many infections like diarrhea and bronchitis are viral, not bacterial. It provides details on selecting antibiotics based on the infection severity, likely bacteria, patient factors, and cost. Empiric antibiotic choices are outlined for various infections. The side effects and costs of common antibiotics are also reviewed. The document emphasizes using antibiotics appropriately only for bacterial infections.
Patient compliance describes how closely a patient follows medical advice, particularly with respect to medication, but also other treatments like device use or therapy. It is important for conditions requiring ongoing treatment, replacement therapies like insulin, or controlling diseases of public health concern. Rates of compliance are assessed through various objective and subjective methods like pill counts, health outcomes, and patient interviews. Improving compliance requires addressing barriers like cost and complex regimens through subsidization, generic drugs, and education by pharmacists and other providers.
The document defines essential medicines as those that satisfy the priority health care needs of the population at all times. It discusses how a limited essential medicines list leads to better health care, drug management, and lower costs. Essential medicines should be available at all times in adequate amounts and strengths, appropriate dosage forms, and assured quality at an affordable price. They are selected based on disease prevalence, evidence on efficacy and safety, and cost-effectiveness. The purpose of an essential medicines list is to make life-saving treatments universally accessible.
The document discusses the concept of essential medicines and rational use of drugs. It defines essential medicines as those that meet the priority health care needs of the population. The WHO publishes a Model List of Essential Medicines every two years to guide countries in developing their own national lists. Educational, managerial, economic and regulatory strategies can be used to promote rational drug use and selection of cost-effective treatments. Pharmacists can play a role through drug selection, inventory control, patient education, and pharmaceutical care.
This document provides an overview of essential drugs and the National List of Essential Medicines (NLEM) in India. It discusses the history and definition of essential drugs as developed by the WHO. Key points covered include the selection criteria and purpose of essential drug lists, as well as the development and features of India's national list. The inclusion and deletion criteria for the NLEM are presented. The importance and impact of essential drug lists at the national and state level in India is also summarized.
This document discusses promoting rational drug use in India under the National Rural Health Mission. It begins by outlining the objectives and defining the problem of irrational drug use in India. Some key points made include that India accounts for 22% of the global disease burden but only produces 2% of global drugs. It then discusses the reasons for irrational drug use, including factors related to patients, prescribers, drug regulation, and the drug supply system. Strategies presented to promote rational drug use include ensuring availability of essential drugs, access and affordability, and rational prescriptions. The challenges of implementation are also acknowledged.
This document provides an overview of drug utilization studies. It defines drug utilization studies as assessing the marketing, distribution, prescription, and use of drugs in a society with emphasis on resulting medical, social and economic consequences. The goals of such studies are to describe drug use patterns, identify early signals of irrational drug use, enable interventions to improve drug use, and provide quality control of drug use. Data sources include large databases, drug regulatory agencies, supplier data, and practice setting data. Future areas of focus include relating drug utilization data to public health trends, pharmacovigilance, pharmacoeconomics, environmental impacts, and pharmacogenetics.
For proper use of medication rational drug use (RDU) is raised. Requirements of rational drug use and it's different steps and roles of pharmacists are described here.
Essential drug concept and rational use of medicinesPravin Prasad
This document discusses the essential medicine concept and rational use of medicines. It defines essential medicines as those that meet the health needs of a population based on effectiveness, safety, and cost. Essential medicine lists include generic drug names, dosage forms, strengths, and indications. Irrational medicine use can lead to ineffective or unsafe treatment, increased costs and resistance. Rational use means using medicines appropriately for each patient's needs in terms of drug choice, dosage, duration, and cost. The document outlines various educational, managerial, regulatory and economic strategies to promote rational medicine use.
Rational use of antibiotics by Dr. Basil TumainiBasil Tumaini
Dr. Basil Tumaini presented a document on rational use of antibiotics. He discussed that antibiotics are commonly misused and overprescribed. Some key points included defining appropriate vs inappropriate antibiotic use, describing different antibiotic classes, and providing guidelines on rational prescribing like only using antibiotics for bacterial infections and avoiding unnecessary combinations. The document concluded with recommendations to only use antibiotics judiciously according to clinical guidelines and provide proper patient education.
1) Rational use of antibiotics is important to avoid adverse effects, antibiotic resistance and increased healthcare costs. Antibiotics should only be used for bacterial infections and are not needed for most viral infections.
2) In selecting an antibiotic, the aetiological agent, patient factors, pharmacokinetic properties of the drug, and efficacy of therapy should be considered. Antibiotics must achieve effective concentrations at the site of infection.
3) Guidelines provide recommendations for common infections, but clinical judgement is also needed. Empiric therapy should be modified based on culture results and the patient's response.
Pharmacovigilance involves monitoring approved drugs to detect adverse effects, assess risks, prevent harm and promote safe use. It aims to improve public health by identifying unknown risks from case reports and studies. Several methods are used including spontaneous reporting, active surveillance and observational studies. Organizations like WHO and regulatory authorities play important roles in pharmacovigilance. The goal is continual assessment of benefit-risk profiles to optimize treatment outcomes.
If you are marketing your product in India you should comply these area of regulation.We give Services in getting manufacturing licences
ACCREDITED CONSULTANTS PVT.LTD
info@acplgroupindia.co.in
+919310040434
The document discusses the concept of essential medicines. It begins by defining essential medicines as those that satisfy the priority health care needs of the majority of the population and should be available at all times in adequate amounts and affordable price. It then outlines the history of the WHO Model List of Essential Medicines, criteria for selecting essential medicines, guidelines for establishing national essential medicines programs, and advantages and disadvantages of essential medicines lists. It also summarizes recommendations from the 18th WHO Model List and 4th Essential Medicines List for Children from 2013.
This document discusses a patient-centric approach to pharmacovigilance. It emphasizes that the patient's healthcare team, which includes physicians, pharmacists, nurses, and the patient, should work together to maximize the benefits and minimize the risks of medication use. The patient should provide their medical history and discuss all medications, supplements, and therapies with their healthcare providers. It is important for patients to read and understand the patient information leaflet that comes with their medications and ask questions about anything unclear. A patient-centric approach requires patients to properly take their medications as directed and report any issues to their healthcare team.
An analysis of wrong practices among pharmacies and pharmacists in India-• Disadvantages of Self Medications Adverse Drug Reactions.Lack of knowledge about dose.Chances of using wrong medication.Risk of disease aggravation Drug interactions.
This document discusses antidepressant use in the Netherlands. It finds that while 900,000 patients are treated for depression each year, only 14% of patients meet eligibility criteria for clinical trials of antidepressants. Many patients do not continue antidepressant treatment as recommended by guidelines. Approximately 30% of patients stop treatment abruptly, experiencing discontinuation side effects, while others create homemade tapering schedules or use schedules from their doctor. The document examines patterns of initiation, adherence, and discontinuation of antidepressant treatment using pharmacy records data.
This document discusses drug risk assessment and pharmacoepidemiology. It notes that clinical trials prior to drug approval are limited in detecting uncommon or long-term side effects. Observational studies using large patient populations are needed to further evaluate drug safety issues and understand rare or long-term side effects. The document compares different pharmacoepidemiological study designs like cohort studies and case-control studies that can be used to investigate drug safety questions following a drug's approval and entry into widespread use.
The Prospective Study Of Adverse Drug Reactions in Surgical Wards of a Tertia...dr venu d
STUDY SUBJECTS : inpatients of surgery departments
PLACE OF STUDY : KIMS Hospital, Bangalore
STUDY PEROID : 12 months ( Jan 2018- Dec 2018 )
STUDY DESIGN : Prospective study
STATISTICAL ANALYSIS : Results are depicted in the form of percentages and graphs.
This study aimed to detect adverse drug reactions (ADRs) induced by cardiovascular drugs using trigger tools in outpatient departments in Nasik City, India. A total of 180 patient prescriptions were analyzed to identify triggers, which are clues that signal potential ADRs. 21 triggers were found in 11.66% of prescriptions. 14 ADRs were detected using the triggers, for a success rate of 71%. However, 6 triggers did not detect any ADRs, for a failure rate of 29%. The most common ADRs detected were hypotension, hypertension, vertigo and cough. This study demonstrates that trigger tools can effectively detect ADRs, but requires further improvement to reduce the failure rate.
This document provides an overview of multidrug-resistant tuberculosis (MDR TB). It defines the different types of drug-resistant TB and discusses the epidemiology and mechanisms of drug resistance. It emphasizes the importance of proper diagnosis and treatment for managing drug-resistant TB. The key points are that improper or incomplete treatment can cause drug resistance to develop, MDR TB requires testing to identify resistance and an individualized treatment regimen using second-line drugs, and treatment must be closely monitored for at least 18-24 months.
THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OFIslam Shallal
This study analyzed medical records from 80 patients at an internal medicine department in Zagazig, Egypt to identify drug-related problems. The study found that 66.2% of patients experienced drug-drug interactions, with the most common being moderate in severity and fair reliability. Errors included high doses, inappropriate frequencies, and wrong or duplicate drugs. The study recommends including clinical pharmacists in prescribing and monitoring to reduce errors and establish treatment guidelines.
- This interim analysis of an ongoing observational study found that topical analgesics may reduce pain severity and interference scores and decrease primary pain complaints and oral pain medication use for patients with neuropathic or musculoskeletal pain.
- Overall patient satisfaction with topical analgesics was high and they were found to be safe and well-tolerated.
- The results were consistent with a previous interim analysis and warrant continuation of the larger OPERA study, though more analysis is still needed.
The document provides an overview of the drug development process. It discusses the major stages of clinical trials from Phase I to Phase IV that drugs must go through for testing and approval. The goals are to determine safety, efficacy, appropriate dosing, and identify any adverse effects. Rigorous clinical trials with control groups, randomization, and large sample sizes are necessary to provide substantial evidence for approval. The overall process takes an average of about 100 months from initial synthesis to approval.
1) A 4-year-old boy presented with ear pain and fullness. He had a fever for 2 days and examination found discharge from his middle ear, leading to a diagnosis of acute otitis media.
2) The doctor wants to compare therapy using topical antibiotics versus oral antibiotics for efficacy.
3) A randomized controlled trial compared topical antibiotic-glucocorticoid ear drops, oral antibiotics, and initial observation in children with tympanostomy tubes and acute otorrhea. It found topical ear drops were more effective than oral antibiotics or initial observation.
Spontaneous Reporting and Prescription Event Monitoring.pptxDrRajeshHadia
This document discusses pharmacovigilance and post-marketing drug safety monitoring. It defines key terms like adverse drug reaction and signal. It explains limitations of pre-approval clinical trials in detecting all ADRs. Various pharmacovigilance strategies are outlined like spontaneous reporting, prescription event monitoring, and case studies. Reporting procedures and timelines are provided. The national pharmacovigilance program in India is described with its structure and operations. Benefits and limitations of spontaneous reporting are highlighted. Prescription event monitoring is explained as a form of post-marketing surveillance.
College 1e jaars Fase IV geneesmiddelenonderzoekRobHeerdink
1. Phase IV drug studies are conducted after a drug has been approved and launched to answer questions about its effects in real-world populations and long-term use.
2. Randomized controlled trials used for drug approval have limitations and may not represent typical patients or capture rare side effects.
3. Observational studies using cohort and case-control designs can provide complementary evidence to clinical trials on drug safety and effectiveness in everyday practice.
For this Discussion, review the case Learning Resources and the DustiBuckner14
For this Discussion, review the case Learning Resources and the case study excerpt presented. Reflect on the case study excerpt and consider the therapy approaches you might take to assess, diagnose, and treat the patient’s health needs.
Case: An elderly widow who just lost her spouse.
Subjective: A patient presents to your primary care office today with chief complaint of insomnia. Patient is 75 YO with PMH of DM, HTN, and MDD. Her husband of 41 years passed away 10 months ago. Since then, she states her depression has gotten worse as well as her sleep habits. The patient has no previous history of depression prior to her husband’s death. She is awake, alert, and oriented x3. Patient normally sees PCP once or twice a year. Patient denies any suicidal ideations. Patient arrived at the office today by private vehicle. Patient currently takes the following medications:
•
Metformin 500mg BID
•
Januvia 100mg daily
•
Losartan 100mg daily
•
HCTZ 25mg daily
•
Sertraline 100mg daily
Current weight: 88 kg
Current height: 64 inches
Temp: 98.6 degrees F
BP: 132/86
By Day 3 of Week 7
Post
a response to each of the following:
• List three questions you might ask the patient if she were in your office. Provide a rationale for why you might ask these questions.
• Identify people in the patient’s life you would need to speak to or get feedback from to further assess the patient’s situation. Include specific questions you might ask these people and why.
• Explain what, if any, physical exams, and diagnostic tests would be appropriate for the patient and how the results would be used.
• List a differential diagnosis for the patient. Identify the one that you think is most likely and explain why.
• List two pharmacologic agents and their dosing that would be appropriate for the patient’s antidepressant therapy based on pharmacokinetics and pharmacodynamics. From a mechanism of action perspective, provide a rationale for why you might choose one agent over the other.
• For the drug therapy you select, identify any contraindications to use or alterations in dosing that may need to be considered based on the client’s ethnicity. Discuss why the contraindication/alteration you identify exists. That is, what would be problematic with the use of this drug in individuals of other ethnicities?
• Include any “check points” (i.e., follow-up data at Week 4, 8, 12, etc.), and indicate any therapeutic changes that you might make based on possible outcomes that may happen given your treatment options chosen.
Respond to the these discussions. All questions need to be addressed.
Discussion 1 En
Three questions to ask the patient and a rationale for asking these questions.
How may I be of assistance today? This question creates a rapport between you and the patients, and it makes her know that the doctor is ready to listen and help her.
What are you doing to cope with grief after losing your husband? This question will help the care ...
This document provides instructions and questions for an assignment on clinical epidemiology and chronic disease epidemiology. It includes 7 questions assessing understanding of key epidemiological concepts like determinants of disease, epidemiological study designs, and interpreting results. Students are asked to apply their knowledge to analyze specific chronic diseases and epidemiological studies, as well as propose public health interventions.
The document discusses medication non-compliance and various ways to measure it. It notes that 50-75% of chronically ill patients do not take their medication as prescribed. Several validated questionnaires are available to measure adherence, including the Morisky Medication Adherence Scale (MMAS-8) and the General Medication Adherence Scale (GMAS). Measuring adherence through questionnaires, pill counts, pharmacy records, and biomarkers can help healthcare providers understand reasons for non-compliance and address them to improve treatment outcomes.
For this Discussion, review the case Learning Resources and the .docxevonnehoggarth79783
For this Discussion, review the case Learning Resources and the case study excerpt presented. Reflect on the case study excerpt and consider the therapy approaches you might take to assess, diagnose, and treat the patient’s health needs.
Case: An elderly widow who just lost her spouse.
Subjective: A patient presents to your primary care office today with chief complaint of insomnia. Patient is 75 YO with PMH of DM, HTN, and MDD. Her husband of 41 years passed away 10 months ago. Since then, she states her depression has gotten worse as well as her sleep habits. The patient has no previous history of depression prior to her husband’s death. She is awake, alert, and oriented x3. Patient normally sees PCP once or twice a year. Patient denies any suicidal ideations. Patient arrived at the office today by private vehicle. Patient currently takes the following medications:
•
Metformin 500mg BID
•
Januvia 100mg daily
•
Losartan 100mg daily
•
HCTZ 25mg daily
•
Sertraline 100mg daily
Current weight: 88 kg
Current height: 64 inches
Temp: 98.6 degrees F
BP: 132/86
By Day 3 of Week 7
Post
a response to each of the following:
• List three questions you might ask the patient if she were in your office. Provide a rationale for why you might ask these questions.
• Identify people in the patient’s life you would need to speak to or get feedback from to further assess the patient’s situation. Include specific questions you might ask these people and why.
• Explain what, if any, physical exams, and diagnostic tests would be appropriate for the patient and how the results would be used.
• List a differential diagnosis for the patient. Identify the one that you think is most likely and explain why.
• List two pharmacologic agents and their dosing that would be appropriate for the patient’s antidepressant therapy based on pharmacokinetics and pharmacodynamics. From a mechanism of action perspective, provide a rationale for why you might choose one agent over the other.
• For the drug therapy you select, identify any contraindications to use or alterations in dosing that may need to be considered based on the client’s ethnicity. Discuss why the contraindication/alteration you identify exists. That is, what would be problematic with the use of this drug in individuals of other ethnicities?
• Include any “check points” (i.e., follow-up data at Week 4, 8, 12, etc.), and indicate any therapeutic changes that you might make based on possible outcomes that may happen given your treatment options chosen.
Respond to the these discussions. All questions need to be addressed.
Discussion 2 Me
Treatment of a Patient with Insomnia
The case presented this week, is that of a 75-year-old widow who just lost her spouse 10-months ago. Th patient presents with chief complaints of insomnia. Past medical history of DM, HTN, and MDD is reported. Since the passing of her husband, she states her depression has gotten worse .
an important ppt for medical students and prescribing clinicians of medicine..... which deals with the methodology of right prescribing...... enjoy reading.... <3.... satya
This document discusses the nurse's responsibilities regarding safe medication administration. Nurses must know the name, use, effects, interactions and monitoring needs of any drugs they administer. They are responsible for ensuring the right patient receives the right drug by the right route at the right time with right documentation. Errors must be reported to improve safety. The nursing process of assessment, diagnosis, planning, implementation and evaluation should be applied to medication administration.
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
This presentation includes basic of PCOS their pathology and treatment and also Ayurveda correlation of PCOS and Ayurvedic line of treatment mentioned in classics.
Executive Directors Chat Leveraging AI for Diversity, Equity, and InclusionTechSoup
Let’s explore the intersection of technology and equity in the final session of our DEI series. Discover how AI tools, like ChatGPT, can be used to support and enhance your nonprofit's DEI initiatives. Participants will gain insights into practical AI applications and get tips for leveraging technology to advance their DEI goals.
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
How to Add Chatter in the odoo 17 ERP ModuleCeline George
In Odoo, the chatter is like a chat tool that helps you work together on records. You can leave notes and track things, making it easier to talk with your team and partners. Inside chatter, all communication history, activity, and changes will be displayed.
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Self Medication Practices
1.
2. “A SURVEY ON SELF MEDICATION PRACTICES
AMONG PHARMACY STUDENTS IN SATARA
COLLEGE OF PHARMACY, SATARA”
By
Mr. BIRUDEV BAPU KALE
B. PHARM (SEM-VIII)
Under the guidance of
Asstt. Prof. Mrs. A. K. SALUNKHE
M. PHARM (PHARMACEUTICS)
3. CONTENTS
1. Introduction
2. Need of present a Survey
3. Objectives
4. Review of Literature
5. Methodology
6. Result & Discussion
7. Conclusions
8. REFERENCES
4. Introduction
Definition of self medication:
The selection and use of medicines by individuals to treat self-
recognized illnesses or symptoms.
Advantages of Self Medication:
Time saving.
Convenient.
Enable patients to control their own chronic conditions.
Economical.
Useful for mild illness.
Reduce the pressure on medical services where health care
personnel are insufficient.
5. Disadvantages of Self Medication:
Adverse Drug Reactions.
Lack of knowledge about dose.
Chances of using wrong medication.
Risk of disease aggravation.
Drug interactions.
6. Common drugs used for Self Medication:
Sr. No. Drug / drug group Brand names
1 Analgesics Saridon
Disprin
2 Antipyretics Calpol
Crocin
3 D cold total
Cough Preparations Glycodin
Corex
Benadryl
4 Antibiotics Amoxil
Trimox
5 Anti-allergics Levorid
Cetzine
6 Gelusil
Antacids Rantac
Zinetac
7. NEED OF PRESENT A SURVEY:
In economically deprived countries most episodes of
illness are treated by self-medication. In a number of
developing countries many drugs are dispensed over the
counter without medical supervision. In this case, self-
medication provides a lower cost-alternative for people
who cannot afford the cost of clinical service.
8. Objectives
To assess the self-medication practice.
To assess common types of illnesses.
To identify frequently used drugs and
determinants of self-medication.
9. REVIEW OF LITERATURE:
Verma Rohit K. et. al., (2010) studied self medication among
professional students in North India. Samples of 1175 young
students belonging to different regions of North India were
selected randomly from two institutions of U. P. Technical
University.
Widayati Aris et.al., (2011) studied self medication with
antibiotics in Yogyakarta City Indonesia. A total of 559
questionnaires were analyzed (response rate = 90%).
10. METHODOLOGY
Study site:
Study was carried out in Satara College of Pharmacy, Satara. It is the
health professional training institute in Satara. It was established in
1999. The college is a pioneer in training Health Professionals. Since
then, the college is expanding its scope of activities and currently it is
training students in Pharmacy Profession.
Study population:
The cross-sectional study was conducted on 100 volunteers
(students and teaching staff) taken as a sample from a total of 500
volunteers (students and teaching staff) in Satara College of
Pharmacy Satara. A random sampling method was used to choose
the respective number of volunteers (students and teachers).
11. Data collection and analysis:
A study with six month illness recall was conducted.
The pre-tested, semi-structured questionnaire was prepared. Data was collected
from January 15 to February 21, 2012. The study subjects were informed that the
information collected would be anonymous; and participation would be totally
voluntary. The age, sex, and year of study were noted. The information regarding
the type of medication, illness for which the medication was used and the reason
for not consulting a doctor was collected. The pattern of drug use over a six-
month period preceding the study was noted. Their attitude toward self-
medication and source of information for those who practiced self-medication
were also recorded. Data were analyzed using Microsoft Excel and the results
were presented using absolute figures and percentages.
12. Questionnaire:
1. Demographic data:
Gender
Age
Class
2. How many minutes of walking does it take for you to reach the nearest health
post or medical store?
3. How many episodes of illness have you had in the preceding six months?
4. What were the main symptoms of your illness?
5. Were there any associated complaints?
6. Have you used medicines on your own without consulting a doctor in the
preceding six months?
7. What type of medicine(s) did you use? Please give their Brand name(s).
8. What was your main reason for not consulting a doctor?
9. If you were not recovered by above medicine, have you consulted a Physician
in the preceding six months?
14. Demographic characteristics of volunteers who reported illness in the last
six months in Satara college of Pharmacy, Satara, in 2011:
Sr. Percentage
Variable Frequency
No. (%)
Sex
1 Male (n = 53) 53 53
Female (n = 47) 47 47
Age
2 18-20 23 23
21 – 24 (n = 57) 57 57
25 and above 20 20
Year
3
B. Pharm I year (n = 2) 02 02
B. Pharm II year (n = 6) 06 06
B. Pharm III year (n = 12) 12 12
B. Pharm IV year (n = 45) 45 45
I year Diploma(n=3) 03 03
07
II year Diploma(n=7) 07
M. Pharm (n=10) 10 10
Teaching staff
15
(n = 15) 15
15. Frequency of reported symptoms / disease:
Sr. No. Type of
symptoms/ Frequency Percentage (%)
diseases
1 Fever / Headache
53 53
/ Body ache
2 Cough and
12 12
Common cold
3 Hyperacidity 27 27
4 Diarrhea/
4 4
Dysentery
5 Eye/ Ear/ Skin
4 4
infections
16. Measures taken by students who reported an illness:
Sr. No.
Measure
Drug source Frequency Percentage
taken
(%)
Pharmacy or
1 Visiting drug shop with 5 5
physician prescription
Pharmacy or
2 Self- drug shop 92 92
medication without
prescription
Drugs left
over from 3 3
prior use
17. Drugs or drug groups used by the volunteers for self-medication:
Sr. No. Drugs/drug
Frequency Percentage (%)
groups
1 NSAIDs 39 41.05
2 Anti-allergics 17 17.89
3 Anti-tussives 4 4.21
4 Antacids 22 23.15
5 Eye/ Ear drops 2 2.10
6 Anti-amoebics 2 2.10
7 Anti-biotics 9 9.47
18. Factors for self-medication:
Sr. No. Reason Frequency Percentage (%)
1 Prior
27 28.42
experience
2 Non-serious
47 49.47
illness
3
Emergency use 10 10.52
4 Cost-
11 11.57
effectiveness
19. Information source for those who practiced self-medication:
Sr. No. Information Percentage
Frequency
source (%)
1 Reading
43 45.26
material
2 Advice from
32 33.68
pharmacist
3 Advice from
14 14.73
friend
4
Others 6 6.31
20. Attitude of volunteers toward self medication practice:
Sr. No. Attitude Frequency Percent(%)
1
Agree 91 91
2
Disagree 05 5
3 Others (no
04 4
comment)
21. CONCLUSIONS
Students in Satara College of Pharmacy Satara,
95%, practiced self-medication. NSAIDs
(e.g.Paracetamol) were the drugs most commonly
used. Prescription drugs such as antibiotics were
involved in self-medication practice. Prior
experience and non-seriousness of the illness
were the most common reasons for self-
medication. Although the self-medication practice
is inevitable; drug authorities and health
professionals need to educate students about the
pros and cons of self medication
22. REFERENCES:
World Health Organization. The Role of pharmacist in Heath Care
System; 1998. Available from:
http://www.apps.who.int/medicinedocs/en/d/Jwhozip32e
Shankar PR, Partha P, Shenoy N. Self-medication and non-doctor
prescription practices in Pokhara valley, Western Nepal: A
questionnaire-based study. BMC Fam Pract. 2002; 3:17.
Mandavi Pramil Tiwarl and Vinay Kapur. Indian J. Pharm .pract1 (1),
Oct-Dec, 2008
V. D. Phalke, D. B. Phalke, P. M. Durgawale. Indian Journal of
Community Medicine Vol31, No.1, Jan-Mar, 2006.
Greenhalgh T. Drug prescription and self-medication in India: an
exploratory survey. Soc Sci Med. 1987; 25:307–318. doi:
10.1016/0277-9536(87)90233-4.
Sharma HB, Gautam RP, Vaidya S., Eds. District development profile
of Nepal. Kathmandu, Informal sector research and study center.
2001.
“A SURVEY ON SELF MEDICATION PRACTICES AMONG PHARMACY STUDENTS IN SATARA COLLEGE OF PHARMACY, SATARA”
INTRODUCTIONOBJECTIVESMETHODOLOGYRESULT & DISCUSSIONCONCLUSION
Questionnaire21. Demographic data:GenderAgeClass 2. How many minutes of walking does it take for you to reach the nearest health post or medical store?3. How many episodes of illness have you had in the preceding six months?4. What were the main symptoms of your illness?5. Were there any associated complaints?6. Have you used medicines on your own without consulting a doctor in the preceding six months?7. What type of medicine(s) did you use? Please give their Brand name(s).8. What was your main reason for not consulting a doctor?9. If you were not recovered by above medicine, have you consulted a Physician in the preceding six months?
RESULT AND DISCUSSION
Demographic characteristics of volunteers who reported illness in the last six months in Satara college of Pharmacy, Satara, in 2011